Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 18.40M | 26.91M | 109.28M | 267.50M | 676.16M |
Gross Profit | 8.98M | 12.39M | 25.40M | 80.26M | 190.61M |
EBITDA | -149.77M | -444.70M | -397.57M | 74.06M | 151.40M |
Net Income | -145.75M | -535.92M | -422.35M | 4.54M | 78.30M |
Balance Sheet | |||||
Total Assets | 2.05B | 2.13B | 2.94B | 3.36B | 3.45B |
Cash, Cash Equivalents and Short-Term Investments | 1.80M | 65.78M | 2.84M | 77.47M | 309.29M |
Total Debt | 717.29M | 834.50M | 813.75M | 793.03M | 746.62M |
Total Liabilities | 1.91B | 2.05B | 2.35B | 2.31B | 2.43B |
Stockholders Equity | 116.64M | 57.29M | 563.12M | 1.02B | 995.93M |
Cash Flow | |||||
Free Cash Flow | -4.63M | 84.51M | -9.66M | -23.13M | 63.46M |
Operating Cash Flow | -4.34M | 84.51M | -9.64M | -22.97M | 65.82M |
Investing Cash Flow | 3.07M | -74.37M | 10.48M | -194.79M | 119.53M |
Financing Cash Flow | -3.16M | -6.73M | -75.37M | -14.10M | -106.08M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
67 Neutral | HK$92.44M | 21.06 | 3.32% | ― | 58.64% | 106.25% | |
62 Neutral | HK$69.60M | ― | -1.93% | ― | 3.63% | -106.98% | |
58 Neutral | HK$14.75B | 4.74 | -3.01% | 5.52% | 3.67% | -54.16% | |
52 Neutral | HK$61.60M | ― | -35.67% | ― | 10.44% | -155.38% | |
48 Neutral | HK$96.66M | ― | -168.91% | ― | -31.98% | 84.33% |
At the annual general meeting held on May 30, 2025, China Greenland Broad Greenstate Group Company Limited successfully passed all proposed resolutions. These included the approval of financial statements, re-election of directors, and authorization for share repurchase and issuance mandates. The unanimous approval of these resolutions reflects strong shareholder support and positions the company for continued strategic growth and operational flexibility.
China Greenland Broad Greenstate Group Company Limited has announced its upcoming annual general meeting scheduled for May 30, 2025, in Shanghai. Key agenda items include the approval of financial statements, re-election of directors, and authorization for the board to fix directors’ and auditors’ remuneration. Additionally, a resolution to grant the directors a mandate to repurchase up to 10% of the company’s shares is proposed, potentially impacting shareholder value and market perception.